Coming Soon

Definigen Limited

Registration Number 07595566

Trading name: Definigen

Definigen specializes in developing cutting-edge in vitro models of human aging and disease, utilizing induced pluripotent stem cells (iPSCs) to provide insights for research and therapeutic purposes.

Company Overview

Company Name
Definigen Limited
Registration Number
07595566
Founded
07 April 2011
Age
13 years
Industry Region
East of England
Registered Postcode
CB22 3AT

Online Profile

Special Flags

Spinout Company
Public Funding Received

Public Funding for Definigen Limited

2019-05-01
Development of an optimised pancreatic cell tool kit to enable accelerated diabetes drug discovery
EU-Funded
2019-01-01
Platform for the development of optimised NAFLD liver cell models to accelerate drug development
Collaborative R&D
2016-01-01
3D culture model for Non-Alcoholic SteatoHepatitis (NASH) drug discovery
Collaborative R&D
2016-01-01
Development of a human 3D in vitro model of pancreatic beta cell health
Collaborative R&D

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.